Organon to acquire Dermavant from Roivant Sciences for $1.2B
PremiumThe FlyOrganon to acquire Dermavant from Roivant Sciences for $1.2B
1d ago
Organon to Acquire Dermavant including its Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1%
Premium
Press Releases
Organon to Acquire Dermavant including its Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1%
1d ago
Organon to acquire Dermavant for consideration up to $1.2B
Premium
The Fly
Organon to acquire Dermavant for consideration up to $1.2B
1d ago
Pulmovant presents positive proof-of-concept data from the Phase 1b ATMOS study of Mosliciguat in Pulmonary Hypertension at European Respiratory Society Congress
PremiumPress ReleasesPulmovant presents positive proof-of-concept data from the Phase 1b ATMOS study of Mosliciguat in Pulmonary Hypertension at European Respiratory Society Congress
9d ago
Roivant Unveils New Pipeline Program Mosliciguat, A Potential First-In-Class and Best-In-Category Inhaled Once-Daily Soluble Guanylate Cyclase (sGC) Activator
Premium
Press Releases
Roivant Unveils New Pipeline Program Mosliciguat, A Potential First-In-Class and Best-In-Category Inhaled Once-Daily Soluble Guanylate Cyclase (sGC) Activator
9d ago
Palantir, Dell Technologies named to join S&P 500: Morning Buzz
Premium
The Fly
Palantir, Dell Technologies named to join S&P 500: Morning Buzz
10d ago
Roivant Sciences reports Q1 EPS 12c, consensus (26c)
PremiumThe FlyRoivant Sciences reports Q1 EPS 12c, consensus (26c)
1M ago
3 Best Stocks to Buy Now, 7/19/2024, According to Top Analysts
Premium
Market News
3 Best Stocks to Buy Now, 7/19/2024, According to Top Analysts
2M ago
Piper Sandler pharmaceuticals analyst holds an analyst/industry conference call
Premium
The Fly
Piper Sandler pharmaceuticals analyst holds an analyst/industry conference call
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100